1 – 31 of 31
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Healthcare costs of dementia diseases before, during and after diagnosis : Longitudinal analysis of 17 years of Swedish register data
(
- Contribution to journal › Article
-
Mark
Characteristics of subjective cognitive decline associated with amyloid positivity
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings
(
- Contribution to journal › Article
- 2021
-
Mark
Sex differences in blood-based biomarkers in individuals with autosomal dominant Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Genetic influence during the early phases of Alzheimer's disease on longitudinal cognitive impairment
(
- Contribution to journal › Article
-
Mark
Genetic interaction study of Alzheimer's disease quantitative biomarkers : A polygenic risk score analysis and evaluation
(
- Contribution to journal › Article
-
Mark
CSF Aβ42 and Aβ40 and their relation to brain soluble and insoluble Aβ in the 5xFAD mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
COVID-19-related loneliness and social isolation in caregivers of people with brain health challenges : The CLIC-Caregiver Global Survey
(
- Contribution to journal › Article
-
Mark
Associations between the APOE-ε2 and APOE-ε4 alleles with resistance and resilience against Alzheimer's disease pathology
(
- Contribution to journal › Article
-
Mark
Neurobiological role of Alzheimer's disease genetic risk factor ApoE on early synaptic changes in Alzheimer-like models
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
(
- Contribution to journal › Article
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
(
- Contribution to journal › Article
-
Mark
In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals
(
- Contribution to journal › Article
- 2018
-
Mark
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people
(
- Contribution to journal › Article
- 2017
-
Mark
The Vascular Impairment of Cognition Classification Consensus Study
(
- Contribution to journal › Article
- 2016
-
Mark
18F-AV1451 pet detects tau pathology in mapt mutation carriers and correlates strongly with immunohistochemistry of tau aggregates
2016) Alzheimer’s Association International Conference 2016 In Alzheimer's and Dementia 12(7 Suppl). p.723-724(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey.
(
- Contribution to journal › Article
-
Mark
CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
A life-course study of cognitive reserve in dementia: Dementia incidence in inpatient registers and mmse test scores in a clinical study in sweden
(
- Contribution to journal › Letter
-
Mark
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
(
- Contribution to journal › Article
-
Mark
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
2015) In Alzheimer's & Dementia(
- Contribution to journal › Article
-
Mark
Various measures of progression predicting mortality in Alzheimer’s disease.
2015) Alzheimer’s Association International Conference (AAIC), 2015 In Alzheimer's & Dementia 11(7 Suppl.). p.293-294(
- Contribution to journal › Published meeting abstract
-
Mark
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study
(
- Contribution to journal › Article
-
Mark
Detection of pre-plaque amyloid aggregation using FTIR
(
- Contribution to journal › Article
-
Mark
The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
(
- Contribution to journal › Article
- 2010
-
Mark
An enzyme activity as a potential biomarker for Alzheimer's disease.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.497-498(
- Contribution to journal › Published meeting abstract
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511(
- Contribution to journal › Published meeting abstract
-
Mark
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
(
- Contribution to journal › Article